Paris, June 28 2021- Chronolife, MedTech and service operator for the diagnosis and monitoring of chronic diseases, and…
Laurent Vandebrouck appointed Chief Executive Officer of Chronolife
Paris (France), November 21, 2018
Chronolife is pleased to announce the appointment of Laurent Vandebrouck to the role of Chief Executive Officer. This start-up co-founded in November 2015 and funded by iBionext is an artificial intelligence company specialized in digital health. Chronolife is currently developing a unique solution which continuously monitors multiple parameters and capable of detecting specific changes in patient’s health.
Before joining Chronolife, Laurent was Managing Director of Qualcomm Life Europe, a company specialized in the development of wireless technologies and the operation of managed services for the connected health market, a company that he joined in 2003. He therefore has a strong experience in connected and digital health including in remote patient monitoring services. He brings his expertise to Chronolife at a time when the company is about to launch a unique range of medical services and devices, starting with a comfortable and washable connected t-shirt that continuously monitors and collects data on 6 physiological parameters (electrocardiogram, abdominal breathing, pulmonary breathing, pulmonary impedance, physical activity and body temperature)
“I am very proud to be joining Chronolife and very enthusiastic at the idea of taking up the firm’s challenges. The technology offered by Chronolife with its connected clothing definitely offers strong competitive advantages. The team has worked brilliantly during the research and development phase by designing a highly innovative and performing t-shirt, which also remains comfortable and discreet”, states Laurent Vandebrouck.
The arrival of Laurent occurs at a strategic moment of the firm’s life, which will now go from its research & development phase, to its manufacturing and commercial phase, requiring the certification of its first medical services and devices.
“We are very pleased to welcome a profile like Laurent to achieve this new step of Chronolife. He is a genuine expert in digital healthcare services, as well as remote patient monitoring services. He also brings a technological perspective, as well as a leadership that will carry us through the next years”, explains Alexia Perouse of iBionext, majority shareholder of Chronolife.
Laurent benefits from more than 25 years of working experience in industry and services, mobile communication technologies, and more recently Cloud and IoT, applied to connected health among other things.
Chronolife is an artificial intelligence company specialized in digital health. Its patented technology is a unique neuromorphic algorithm called HOTS (Hierarchy Of even-based Time Surfaces), which analyses several data flows continuously, to characterize clinical events. Chronolife has developed a smart wearable that integrates various sensors to continuously monitor physiological data. This data is analyzed by the smartphone application on patient’s phone that uses HOTS technology to conduct data fusion. It is capable of detecting changes in a patient’s health and triggering alerts to healthcare professionals to predict acute pathological episodes.
IBionext is a management company that supports and funds the growth of innovative firms in the biotech, medtech and connected medical devices. Initiated as a start-up network since 2012, iBionext helps turning disruptive technologies into innovative firms and worldwide leaders. All of the firms social head offices are gathered within the “Passage de l’Innovation”, Paris. The iBionext network took part in the creation and growth of 9 firms – Pixium Vision (Euronext : PIX), GenSight Biologics (Euronext : SIGHT), Gecko Biomedical, Prophesee, Chronolife, BrainEver, Tilak Healthcare, Gray Matter Labs, Tricper.
To learn more : ibionext.com¹ IBionext is a management company and studio start-up, specialized in the creation and development of disruptive healthcare companies
Agence Weber Shandwick
nkalasa(@)webershandwick.com – 01 47 59 56 33